Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
72 /100
HIGH RISK
Score updated Aug 28, 2026

ONCY — Oncolytics Biotech Inc. Dilution Risk Tracker

Track ONCY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ONCY — Get alerts when the score changes →

As of August 28, 2026, Oncolytics Biotech Inc. (ONCY) has a DilutionWatch DilutionScore of 72/100, rated HIGH dilution risk. Oncolytics Biotech Inc. has a market capitalization of $124.13M, 127.51M shares outstanding, 60 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
66
💰 Cash Runway
95
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 70%
• 50-day avg $0.94 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 2.5 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (72/100)
🔔 Track ONCY — Get forecast alerts →

Market Data

Market Cap$124.13M
Shares Outstanding127.51M
Float113.67M
Cash$4.12M
Debt$563.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 42.9% shares (2026Q1 vs prior)
60 institutional holders · 4.01M shares
#1 MORGAN STANLEY 837.9K shares
#2 RENAISSANCE TECHNOLOGIES LLC 715.8K shares
#3 Sandbox Financial Partners, LLC 400.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest8.23M
Days to Cover7.1
% of Float7.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual ONCY Dilution Snapshot

Oncolytics Biotech Inc. (ONCY) has a DilutionScore of 72/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track ONCY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ONCY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ONCY
ONCY FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.